Showing results (71-80 of 616) with videos related to
Sort By:
Pageof 62
Blood|March 25, 2000
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapyR M Lemoli, G Martinelli, E Zamagni, et al.Blood|February 15, 1996
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cellsR M Lemoli, A Fortuna, M R Motta, et al.Bone Marrow Transplantation|July 25, 1998
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myelomaM Cavo, G Bandini, M Benni, et al.Acta Haematologica|January 1, 1977
Acute promyelocytic leukemia: results of therapy and analysis of 13 casesD Ruggero, M Baccarani, A Guarini, et al.Blood|September 1, 1984
Effect of a thymic factor on T lymphocytes in B cell chronic lymphocytic leukemia: in vitro and in vivo studiesF Lauria, D Raspadori, S TuraLa Ricerca in Clinica E in Laboratorio|January 1, 1983
[Polycythemic hyperviscosity syndromes]S Tura, C Finelli, P RicciBollettino Dell'Istituto Sieroterapico Milanese|July 31, 1978
Therapy of chronic myeloid leukemia (CML): interim report on protocols CML/73 and CML/74M Baccarani, D Ruggero, S TuraBritish Journal of Haematology|January 1, 1981
Staging of chronic myeloid leukaemiaS Tura, M Baccarani, G CorbelliJournal of Hematotherapy|August 1, 1996
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myelomaR M Lemoli, M Cavo, A FortunaEuropean Journal of Clinical Pharmacology|January 1, 1993
Deflazacort in the treatment of haematologic disordersM Gobbi, M ScudelettiPageof 62